MTLS

Materialise

5.26 USD
-0.05
0.94%
Updated Jul 30, 2:05 PM EDT
1 day
-0.94%
5 days
-9.31%
1 month
-6.90%
3 months
2.33%
6 months
-39.19%
Year to date
-25.81%
1 year
-6.90%
5 years
-77.94%
10 years
-41.43%
 

About: Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Employees: 2,514

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.72% less ownership

Funds ownership: 14.21% [Q4 2024] → 13.49% (-0.72%) [Q1 2025]

14% less funds holding

Funds holding: 76 [Q4 2024] → 65 (-11) [Q1 2025]

23% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 26

34% less capital invested

Capital invested by funds: $59.1M [Q4 2024] → $39.2M (-$19.9M) [Q1 2025]

52% less call options, than puts

Call options by funds: $982K | Put options by funds: $2.07M

61% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 18

Research analyst outlook

We haven’t received any recent analyst ratings for MTLS.

Financial journalist opinion

Based on 5 articles about MTLS published over the past 30 days

Negative
Seeking Alpha
1 day ago
Materialise: Automotive Weakness Is Undermining The Stock
Materialise's Q2 results were weak due to European automotive headwinds and macro uncertainty. Materialise's Medical segment continues to thrive, and its Software business is nearly done transitioning to a recurring revenue model. Medical segment strength justifies a higher valuation, but the Manufacturing business must stabilize before the stock can meaningfully re-rate.
Materialise: Automotive Weakness Is Undermining The Stock
Neutral
Seeking Alpha
6 days ago
Materialise NV (MTLS) Q2 2025 Earnings Call Transcript
Materialise NV (NASDAQ:MTLS ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Alexander Craeymeersch - Kepler Cheuvreux, Research Division Troy Donavon Jensen - Cantor Fitzgerald & Co., Research Division Harriet Fried - Unidentified Company Operator Good day, and thank you for standing by. Welcome to the Second Quarter 2025 Materialise NV Financial Results Conference Call.
Materialise NV (MTLS) Q2 2025 Earnings Call Transcript
Neutral
Business Wire
6 days ago
Materialise Reports Second Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025. Highlights – Second Quarter 2025 Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth. Gross profit as a perce.
Materialise Reports Second Quarter 2025 Results
Positive
Seeking Alpha
1 week ago
Materialise Q2 Preview: Anticipating Strong Medical Growth; Initiating With 'Buy'
I rate Materialise a 'buy' with a fair value of $8.83, driven by its unique integrated 3D printing software and hardware solutions. Materialise's strategic focus on software and medical segments strengthens its competitive edge, with medical now 47% of revenue and growing double digits. Recurring software revenue exceeds 80% in its segment, supporting margin expansion, customer retention, and reducing business cyclicality.
Materialise Q2 Preview: Anticipating Strong Medical Growth; Initiating With 'Buy'
Neutral
Business Wire
2 weeks ago
Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the second quarter ended June 30, 2025 on Thursday, July 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the second quarter 2025 financial results on Thursday, July 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by p.
Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025
Neutral
GlobeNewsWire
2 months ago
Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025
LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting (AGM) on Tuesday, June 3, 2025, at 10:00 am CET.
Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025
Positive
Seeking Alpha
2 months ago
Materialise: Medical Segment Continues To Thrive
While Materialise's Q1 results were mixed they exceeded low investor expectations, with the company's Medical segment continuing to excel. Market conditions are likely to remain challenging, but lower energy costs and increased defense spending in Europe could help to offset this. Materialise's Medical segment alone more than justifies its current market capitalization.
Materialise: Medical Segment Continues To Thrive
Neutral
Seeking Alpha
3 months ago
Materialise NV (MTLS) Q1 2025 Earnings Call Transcript
Materialise NV (NASDAQ:MTLS ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Harriet Fried - Alliance Advisors, IR Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Operator Good day and thank you for standing by. Welcome to the First Quarter 2025 Materialise Financial Results Conference Call.
Materialise NV (MTLS) Q1 2025 Earnings Call Transcript
Neutral
Business Wire
3 months ago
Materialise Reports First Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from sof.
Materialise Reports First Quarter 2025 Results
Neutral
Business Wire
3 months ago
Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2025 on Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the first quarter 2025 financial results on Thursday, April 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by.
Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025
Charts implemented using Lightweight Charts™